166 related articles for article (PubMed ID: 31397441)
41. Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli.
Bohnert JA; Szymaniak-Vits M; Schuster S; Kern WV
J Antimicrob Chemother; 2011 Sep; 66(9):2057-60. PubMed ID: 21700628
[TBL] [Abstract][Full Text] [Related]
42. Unidirectional peristaltic movement in multisite drug binding pockets of AcrB from molecular dynamics simulations.
Feng Z; Hou T; Li Y
Mol Biosyst; 2012 Oct; 8(10):2699-709. PubMed ID: 22825052
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance.
Jin C; Alenazy R; Wang Y; Mowla R; Qin Y; Tan JQE; Modi ND; Gu X; Polyak SW; Venter H; Ma S
Bioorg Med Chem Lett; 2019 Apr; 29(7):882-889. PubMed ID: 30755336
[TBL] [Abstract][Full Text] [Related]
44. Optimization of a novel series of pyranopyridine RND efflux pump inhibitors.
Aron Z; Opperman TJ
Curr Opin Microbiol; 2016 Oct; 33():1-6. PubMed ID: 27232955
[TBL] [Abstract][Full Text] [Related]
45. Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump.
Kinana AD; Vargiu AV; May T; Nikaido H
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1405-10. PubMed ID: 26787896
[TBL] [Abstract][Full Text] [Related]
46. The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance.
Seeger MA; Diederichs K; Eicher T; Brandstätter L; Schiefner A; Verrey F; Pos KM
Curr Drug Targets; 2008 Sep; 9(9):729-49. PubMed ID: 18781920
[TBL] [Abstract][Full Text] [Related]
47. Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones.
Huguet A; Pensec J; Soumet C
J Appl Microbiol; 2013 May; 114(5):1294-9. PubMed ID: 23414263
[TBL] [Abstract][Full Text] [Related]
48. Covalently Linked Trimers of RND (Resistance-Nodulation-Division) Efflux Transporters to Study Their Mechanism of Action: Escherichia coli AcrB Multidrug Exporter as an Example.
Nikaido H
Methods Mol Biol; 2018; 1700():147-165. PubMed ID: 29177830
[TBL] [Abstract][Full Text] [Related]
49. Crystallographic Analysis of Drug and Inhibitor-Binding Structure of RND-Type Multidrug Exporter AcrB in Physiologically Relevant Asymmetric Crystals.
Nakashima R; Sakurai K; Yamaguchi A
Methods Mol Biol; 2018; 1700():25-36. PubMed ID: 29177823
[TBL] [Abstract][Full Text] [Related]
50. Water-mediated interactions enable smooth substrate transport in a bacterial efflux pump.
Vargiu AV; Ramaswamy VK; Malvacio I; Malloci G; Kleinekathöfer U; Ruggerone P
Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):836-845. PubMed ID: 29339082
[TBL] [Abstract][Full Text] [Related]
51. Increase of multidrug efflux pump expression in fluoroquinolone-resistant Salmonella mutants induced by ciprofloxacin selective pressure.
Kang HW; Woo GJ
Res Vet Sci; 2014 Oct; 97(2):182-6. PubMed ID: 25128419
[TBL] [Abstract][Full Text] [Related]
52. Deciphering the molecular and functional basis of TMexCD1: the plasmid-encoded efflux pump of resistance-nodulation-division superfamily.
Shang Y; Zhang Y; Wang R; Peng Y; Ding B; Liu Y; Li C; Feng L; Liu H; Yang C; Tang Y
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0167823. PubMed ID: 38477539
[TBL] [Abstract][Full Text] [Related]
53. The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli: an in silico approach.
Abdel-Halim H; Al Dajani A; Abdelhalim A; Abdelmalek S
Appl Microbiol Biotechnol; 2019 Aug; 103(15):6309-6318. PubMed ID: 31209525
[TBL] [Abstract][Full Text] [Related]
54. Purification, crystallization and preliminary diffraction studies of AcrB, an inner-membrane multi-drug efflux protein.
Pos KM; Diederichs K
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1865-7. PubMed ID: 12351840
[TBL] [Abstract][Full Text] [Related]
55. Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.
Li B; Yao Q; Pan XC; Wang N; Zhang R; Li J; Ding G; Liu X; Wu C; Ran D; Zheng J; Zhou H
J Antimicrob Chemother; 2011 Apr; 66(4):769-77. PubMed ID: 21393180
[TBL] [Abstract][Full Text] [Related]
56. The induced and intrinsic resistance of
Dai J-S; Xu J; Shen H-J; Chen N-P; Zhu B-Q; Xue Z-J; Chen H-H; Ding Z-S; Ding R; Qian C-D
Microbiol Spectr; 2024 Jan; 12(1):e0323723. PubMed ID: 38038452
[TBL] [Abstract][Full Text] [Related]
57.
Samreen ; Qais FA; Ahmad I
J Biomol Struct Dyn; 2023 Apr; 41(6):2189-2201. PubMed ID: 35067192
[TBL] [Abstract][Full Text] [Related]
58. Effect of site-directed mutations in multidrug efflux pump AcrB examined by quantitative efflux assays.
Kinana AD; Vargiu AV; Nikaido H
Biochem Biophys Res Commun; 2016 Nov; 480(4):552-557. PubMed ID: 27789287
[TBL] [Abstract][Full Text] [Related]
59. Secondary multidrug efflux pump mutants alter Escherichia coli biofilm growth in the presence of cationic antimicrobial compounds.
Bay DC; Stremick CA; Slipski CJ; Turner RJ
Res Microbiol; 2017 Apr; 168(3):208-221. PubMed ID: 27884783
[TBL] [Abstract][Full Text] [Related]
60. Analysis of AcrB in Klebsiella pneumoniae reveals natural variants promoting enhanced multidrug resistance.
Li Y; Cross TS; Dörr T
Res Microbiol; 2022; 173(3):103901. PubMed ID: 34863884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
